173 related articles for article (PubMed ID: 16026300)
21. [Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients--an interim analysis].
Pajonk FG; Schreiner A; Peters S; Rettig K; Degner D; Rüther E
Fortschr Neurol Psychiatr; 2003 May; 71(5):249-54. PubMed ID: 12740756
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
Jones B; Taylor CC; Meehan K
J Clin Psychiatry; 2001; 62 Suppl 2():22-4. PubMed ID: 11232747
[TBL] [Abstract][Full Text] [Related]
23. Continuum of care: stabilizing the acutely agitated patient.
Bellnier TJ
Am J Health Syst Pharm; 2002 Sep; 59(17 Suppl 5):S12-8. PubMed ID: 12227082
[TBL] [Abstract][Full Text] [Related]
24. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
[TBL] [Abstract][Full Text] [Related]
25. The use of intramuscular benzodiazepines and antipsychotic agents in the treatment of acute agitation or violence in the emergency department.
Rund DA; Ewing JD; Mitzel K; Votolato N
J Emerg Med; 2006 Oct; 31(3):317-24. PubMed ID: 16982374
[TBL] [Abstract][Full Text] [Related]
26. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
Battaglia J; Houston JP; Ahl J; Meyers AL; Kaiser CJ
Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.
Chan HY; Ree SC; Su LW; Chen JJ; Chou SY; Chen CK; Chen YS
J Clin Psychopharmacol; 2014 Jun; 34(3):355-8. PubMed ID: 24743717
[TBL] [Abstract][Full Text] [Related]
28. Agitation in schizophrenia: origins and evidence-based treatment.
Citrome L
Curr Opin Psychiatry; 2021 May; 34(3):216-221. PubMed ID: 33395103
[TBL] [Abstract][Full Text] [Related]
29. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
[TBL] [Abstract][Full Text] [Related]
30. Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia.
Gonzalez D; Bienroth M; Curtis V; Debenham M; Jones S; Pitsi D; George M
Curr Med Res Opin; 2013 Mar; 29(3):241-50. PubMed ID: 23323879
[TBL] [Abstract][Full Text] [Related]
31. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
Daniel DG; Potkin SG; Reeves KR; Swift RH; Harrigan EP
Psychopharmacology (Berl); 2001 May; 155(2):128-34. PubMed ID: 11401000
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment of schizophrenia.
Leucht S; Heres S; Kissling W; Davis JM
Fortschr Neurol Psychiatr; 2013 May; 81(5):e1-13. PubMed ID: 23702802
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological management of agitation in emergency settings.
Yildiz A; Sachs GS; Turgay A
Emerg Med J; 2003 Jul; 20(4):339-46. PubMed ID: 12835344
[TBL] [Abstract][Full Text] [Related]
34. Treatment of agitation in patients with schizophrenia.
Marder SR
J Clin Psychiatry; 2008 Jun; 69(6):e17. PubMed ID: 18683992
[TBL] [Abstract][Full Text] [Related]
35. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
[TBL] [Abstract][Full Text] [Related]
36. Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.
Marder SR; Sorsaburu S; Dunayevich E; Karagianis JL; Dawe IC; Falk DM; Dellva MA; Carlson JL; Cavazzoni PA; Baker RW
J Clin Psychiatry; 2010 Apr; 71(4):433-41. PubMed ID: 20156413
[TBL] [Abstract][Full Text] [Related]
37. Management of the agitated patient. A pharmacological update.
McGough JJ; Bona JR
N C Med J; 1988 Oct; 49(10):497-9. PubMed ID: 2903452
[No Abstract] [Full Text] [Related]
38. Management of agitation in the acute psychotic patient--efficacy without excessive sedation.
Cañas F
Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S108-14. PubMed ID: 17336765
[TBL] [Abstract][Full Text] [Related]
39. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and therapeutic aspects of agitation].
San L
Encephale; 2007 Jun; 33 Pt 3():S375-9. PubMed ID: 19101354
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
